Journal article

Clinical challenges and future therapeutic approaches for neuronal ceroid lipofuscinosis

Sara E Mole, Glenn Anderson, Heather A Band, Samuel F Berkovic, Jonathan D Cooper, Sophia-Martha Kleine Holthaus, Tristan R Mckay, Diego L Medina, Ahad A Rahim, Angela Schulz, Alexander J Smith

LANCET NEUROLOGY | ELSEVIER SCIENCE INC | Published : 2019

Abstract

Treatment of the neuronal ceroid lipofuscinoses, also known as Batten disease, is at the start of a new era because of diagnostic and therapeutic advances relevant to this group of inherited neurodegenerative and life-limiting disorders that affect children. Diagnosis has improved with the use of comprehensive DNA-based tests that simultaneously screen for many genes. The identification of disease-causing mutations in 13 genes provides a basis for understanding the molecular mechanisms underlying neuronal ceroid lipofuscinoses, and for the development of targeted therapies. These targeted therapies include enzyme replacement therapies, gene therapies targeting the brain and the eye, cell the..

View full abstract

University of Melbourne Researchers